메뉴 건너뛰기




Volumn 203, Issue 6, 2014, Pages W706-W714

Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC

Author keywords

Doxorubicin drug eluting beads transarterial chemoembolization (DEB TACE); Small versus large DEB TACE; Unresectable hepatocellular carcinoma (HCC)

Indexed keywords

ALPHA FETOPROTEIN; DOXORUBICIN; ANTINEOPLASTIC ANTIBIOTIC; DELAYED RELEASE FORMULATION;

EID: 84925230322     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.13.12308     Document Type: Article
Times cited : (60)

References (33)
  • 1
    • 34250020201 scopus 로고    scopus 로고
    • Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
    • El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132:2557-2576
    • (2007) Gastroenterology , vol.132 , pp. 2557-2576
    • El-Serag, H.B.1    Rudolph, K.L.2
  • 3
    • 7044231396 scopus 로고    scopus 로고
    • Hepatocellular carcinoma: Recent trends in the United States
    • El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127(5 suppl):S27-S34
    • (2004) Gastroenterology , vol.127 , Issue.5 , pp. S27-S34
    • El-Serag, H.B.1
  • 4
    • 33751210578 scopus 로고    scopus 로고
    • Interventional treatments for hepatocellular carcinoma
    • Guan YS, Liu Y. Interventional treatments for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2006; 5:495-500
    • (2006) Hepatobiliary Pancreat Dis Int , vol.5 , pp. 495-500
    • Guan, Y.S.1    Liu, Y.2
  • 5
    • 33847702042 scopus 로고    scopus 로고
    • Liver resection and transplantation in the management of hepatocellular carcinoma: A review
    • Kassahun WT, Fangmann J, Harms J, Hauss J, Bartels M. Liver resection and transplantation in the management of hepatocellular carcinoma: a review. Exp Clin Transplant 2006; 4:549-558
    • (2006) Exp Clin Transplant , vol.4 , pp. 549-558
    • Kassahun, W.T.1    Fangmann, J.2    Harms, J.3    Hauss, J.4    Bartels, M.5
  • 6
    • 28844480321 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma
    • Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236
    • (2005) Hepatology , vol.42 , pp. 1208-1236
    • Bruix, J.1    Sherman, M.2
  • 7
    • 84864438332 scopus 로고    scopus 로고
    • Chemoembolization for hepatocellular carcinoma
    • Lencioni R. Chemoembolization for hepatocellular carcinoma. Semin Oncol 2012; 39:503-509
    • (2012) Semin Oncol , vol.39 , pp. 503-509
    • Lencioni, R.1
  • 8
    • 3843117688 scopus 로고    scopus 로고
    • The role of tumor ablation in bridging patients to liver transplantation
    • Johnson EW, Holck PS, Levy AE, Yeh MM, Yeung RS. The role of tumor ablation in bridging patients to liver transplantation. Arch Surg 2004; 139:825-830
    • (2004) Arch Surg , vol.139 , pp. 825-830
    • Johnson, E.W.1    Holck, P.S.2    Levy, A.E.3    Yeh, M.M.4    Yeung, R.S.5
  • 9
    • 0038173318 scopus 로고    scopus 로고
    • Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome
    • Graziadei IW, Sandmueller H, Waldenberger P, et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003; 9:557-563
    • (2003) Liver Transpl , vol.9 , pp. 557-563
    • Graziadei, I.W.1    Sandmueller, H.2    Waldenberger, P.3
  • 10
    • 2442489095 scopus 로고    scopus 로고
    • Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation
    • Hayashi PH, Ludkowski M, Forman LM, et al. Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transplant 2004; 4:782-787
    • (2004) Am J Transplant , vol.4 , pp. 782-787
    • Hayashi, P.H.1    Ludkowski, M.2    Forman, L.M.3
  • 11
    • 0037129704 scopus 로고    scopus 로고
    • Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial
    • Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359:1734-1739
    • (2002) Lancet , vol.359 , pp. 1734-1739
    • Llovet, J.M.1    Real, M.I.2    Montana, X.3
  • 12
    • 0036237822 scopus 로고    scopus 로고
    • Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
    • Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35:1164-1171
    • (2002) Hepatology , vol.35 , pp. 1164-1171
    • Lo, C.M.1    Ngan, H.2    Tso, W.K.3
  • 13
    • 84862496492 scopus 로고    scopus 로고
    • Advancedstage hepatocellular carcinoma: Transarterial chemoembolization versus sorafenib
    • Pinter M, Hucke F, Graziadei I, et al. Advancedstage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib. Radiology 2012; 263:590-599
    • (2012) Radiology , vol.263 , pp. 590-599
    • Pinter, M.1    Hucke, F.2    Graziadei, I.3
  • 14
    • 77949264899 scopus 로고    scopus 로고
    • Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: Results of the PRECISION v study
    • Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 2010; 33:41-52
    • (2010) Cardiovasc Intervent Radiol , vol.33 , pp. 41-52
    • Lammer, J.1    Malagari, K.2    Vogl, T.3
  • 15
    • 41049116317 scopus 로고    scopus 로고
    • Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: Results of an open-label study of 62 patients
    • Malagari K, Chatzimichael K, Alexopoulou E, et al. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Intervent Radiol 2008; 31:269-280
    • (2008) Cardiovasc Intervent Radiol , vol.31 , pp. 269-280
    • Malagari, K.1    Chatzimichael, K.2    Alexopoulou, E.3
  • 16
    • 77950810261 scopus 로고    scopus 로고
    • Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocellular carcinoma (HCC)
    • Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocellular carcinoma (HCC). J Surg Oncol 2010; 101:476-480
    • (2010) J Surg Oncol , vol.101 , pp. 476-480
    • Dhanasekaran, R.1    Kooby, D.A.2    Staley, C.A.3    Kauh, J.S.4    Khanna, V.5    Kim, H.S.6
  • 17
    • 84867579825 scopus 로고    scopus 로고
    • Transcatheter treatment of hepatocellular carcinoma with doxorubicin-loaded DC Bead (DEBDOX): Technical recommendations
    • Lencioni R, de Baere T, Burrel M, et al. Transcatheter treatment of hepatocellular carcinoma with doxorubicin-loaded DC Bead (DEBDOX): technical recommendations. Cardiovasc Intervent Radiol 2012; 35:980-985
    • (2012) Cardiovasc Intervent Radiol , vol.35 , pp. 980-985
    • Lencioni, R.1    De Baere, T.2    Burrel, M.3
  • 18
    • 84874784518 scopus 로고    scopus 로고
    • Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: Comparison of small-versus medium-size particles
    • Padia SA, Shivaram G, Bastawrous S, et al. Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles. J Vasc Interv Radiol 2013; 24:301-306
    • (2013) J Vasc Interv Radiol , vol.24 , pp. 301-306
    • Padia, S.A.1    Shivaram, G.2    Bastawrous, S.3
  • 21
    • 0036085956 scopus 로고    scopus 로고
    • Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials
    • Camma C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002; 224:47-54
    • (2002) Radiology , vol.224 , pp. 47-54
    • Camma, C.1    Schepis, F.2    Orlando, A.3
  • 22
    • 77953560673 scopus 로고    scopus 로고
    • Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: A preliminary study
    • Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study. HPB (Oxford) 2010; 12:174-180
    • (2010) HPB (Oxford) , vol.12 , pp. 174-180
    • Dhanasekaran, R.1    Kooby, D.A.2    Staley, C.A.3    Kauh, J.S.4    Khanna, V.5    Kim, H.S.6
  • 23
    • 84874775503 scopus 로고    scopus 로고
    • Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma
    • Prajapati HJ, Dhanasekaran R, El-Rayes BF, et al. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma. J Vasc Interv Radiol 2013; 24:307-315
    • (2013) J Vasc Interv Radiol , vol.24 , pp. 307-315
    • Prajapati, H.J.1    Dhanasekaran, R.2    El-Rayes, B.F.3
  • 24
    • 84866707150 scopus 로고    scopus 로고
    • Safety and feasibility of sameday discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization
    • Prajapati HJ, Rafi S, El-Rayes BF, Kauh JS, Kooby DA, Kim HS. Safety and feasibility of sameday discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization. J Vasc Interv Radiol 2012; 23:1286-1293
    • (2012) J Vasc Interv Radiol , vol.23 , pp. 1286-1293
    • Prajapati, H.J.1    Rafi, S.2    El-Rayes, B.F.3    Kauh, J.S.4    Kooby, D.A.5    Kim, H.S.6
  • 25
    • 80054925991 scopus 로고    scopus 로고
    • Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma
    • Sacco R, Bargellini I, Bertini M, et al. Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol 2011; 22:1545-1552
    • (2011) J Vasc Interv Radiol , vol.22 , pp. 1545-1552
    • Sacco, R.1    Bargellini, I.2    Bertini, M.3
  • 26
    • 84861192547 scopus 로고    scopus 로고
    • Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using drug eluting beads: Implications for clinical practice and trial design
    • Burrel M, Reig M, Forner A, et al. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using drug eluting beads: implications for clinical practice and trial design. J Hepatol 2012; 56:1330-1335
    • (2012) J Hepatol , vol.56 , pp. 1330-1335
    • Burrel, M.1    Reig, M.2    Forner, A.3
  • 27
    • 79959517589 scopus 로고    scopus 로고
    • Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma
    • Ferrer Puchol MD, la Parra C, Esteban E, et al. Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma. Radiologia 2011; 53:246-253
    • (2011) Radiologia , vol.53 , pp. 246-253
    • Ferrer Puchol, M.D.1    La Parra, C.2    Esteban, E.3
  • 28
    • 84875601700 scopus 로고    scopus 로고
    • RECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)
    • Prajapati HJ, Spivey JR, Hanish SI, et al. RECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE). Ann Oncol 2012; 24:965-973
    • (2012) Ann Oncol , vol.24 , pp. 965-973
    • Prajapati, H.J.1    Spivey, J.R.2    Hanish, S.I.3
  • 29
    • 41949093036 scopus 로고    scopus 로고
    • Chemo-embolization for unresectable hepatocellular carcinoma with different sizes of embolization particles
    • Amesur NB, Zajko AB, Carr BI. Chemo-embolization for unresectable hepatocellular carcinoma with different sizes of embolization particles. Dig Dis Sci 2008; 53:1400-1404
    • (2008) Dig Dis Sci , vol.53 , pp. 1400-1404
    • Amesur, N.B.1    Zajko, A.B.2    Carr, B.I.3
  • 30
    • 44149096218 scopus 로고    scopus 로고
    • Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma
    • Maluccio MA, Covey AM, Porat LB, et al. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 2008; 19:862-869
    • (2008) J Vasc Interv Radiol , vol.19 , pp. 862-869
    • Maluccio, M.A.1    Covey, A.M.2    Porat, L.B.3
  • 31
    • 33747496271 scopus 로고    scopus 로고
    • Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization
    • Lewis AL, Taylor RR, Hall B, Gonzalez MV, Willis SL, Stratford PW. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol 2006; 17:1335-1343
    • (2006) J Vasc Interv Radiol , vol.17 , pp. 1335-1343
    • Lewis, A.L.1    Taylor, R.R.2    Hall, B.3    Gonzalez, M.V.4    Willis, S.L.5    Stratford, P.W.6
  • 32
    • 0242491490 scopus 로고    scopus 로고
    • Postchemoembolisation syndrome-tumour necrosis or hepatocyte injury
    • Wigmore SJ, Redhead DN, Thompson BN, et al. Postchemoembolisation syndrome-tumour necrosis or hepatocyte injury? Br J Cancer 2003; 89:1423-1427
    • (2003) Br J Cancer , vol.89 , pp. 1423-1427
    • Wigmore, S.J.1    Redhead, D.N.2    Thompson, B.N.3
  • 33
    • 36348969465 scopus 로고    scopus 로고
    • Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk
    • Kothary N, Weintraub JL, Susman J, Rundback JH. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk. J Vasc Interv Radiol 2007; 18:1517-1526
    • (2007) J Vasc Interv Radiol , vol.18 , pp. 1517-1526
    • Kothary, N.1    Weintraub, J.L.2    Susman, J.3    Rundback, J.H.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.